Inceptive
inceptive.com
Actively hiring
Machine Learning
Drug Discovery AI
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$100M
1 round on record
Latest round
$100M
Venture round · Sep 2023 · 3 yr ago
Team
51-200
employees, estimated range
Hiring now
5
open roles
Backers
2
Andreessen Horowitz, Obvious Ventures
The money's age
Long since its last round
37 months since the last round · hiring slowed
Momentum
25/100
a new city, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2023 | $100M | Andreessen Horowitz lead | Nasdaq |
Backed byfrom the funds' portfolios and accelerator catalogs
Andreessen Horowitz 
Obvious Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Inductive Bio builds machine learning models that predict the absorption, distribution, metabolism and toxicity properties of drug…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
Terray Therapeutics is a venture-backed biotechnology company that combines nanotechnology, experimental science, machine learning and…
Latent Labs builds generative models that design proteins from a natural language description of the desired function. Founded in 2023 by a…
deepmirror is an AI-native drug design platform built around curated, non-public experimental molecule property measurements such as…
How Inceptive hires
Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%
Inceptive scores B on the Alion truth index (A is best, E worst), measured over 5 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
Overview
Inceptive is a company founded in 2021 by a co-author of the transformer paper to design RNA molecules with deep learning. It treats messenger and other RNA as programmable biological software, training models on large experimental datasets it generates itself. The goal is to write molecules that produce a desired biological effect rather than screening existing candidates.
News
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive PharmExec
Alnylam Pharmaceuticals has partnered with Inceptive to apply generative AI to siRNA design, pairing Inceptive
Read more
Report
Alnylam Pharmaceuticals (ALNY), Inceptive Form $2B Partnership to Advance RNAi Drug Discovery
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the most promising long-term stocks to buy according to analysts. On June 3, Alnylam and Inceptive Nucleics, which builds foundation models of life, announced a collaboration valued at up to $2 billion
Read more
Report
Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam announced a three-year collaboration with Inceptive, worth up to $2 billion, with $30 million up front in cash and equity in the startup.
Read more
Report
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
CAMBRIDGE, Mass. & PALO ALTO, Calif., June 03, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Inceptive Nucleics, Inc., which builds foundation models of life, today announced a strategic collaboration agree
Read more
Report
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
CAMBRIDGE, Mass.& PALO ALTO, Calif.---- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, and Inceptive Nucleics, Inc., which builds foundation models of life, today announced a strategic collaboration agreement to increase the pace of
Read more
Report
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
Read more
Report
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
Read more
Report
Inceptive: Revolutionizing RNA with AI for Drug Development
Discover how Jakob Uszkoreit and Rhiju Das are revolutionizing drug development at Inceptive, merging AI and biology for groundbreaking solutions.
Read more
Report
After leaving Google, Jakob Uszkoreit started Inceptive to apply AI to drug development
Inceptive CEO Jakob Uszkoreit helped invent the tech behind generative AI. Now, he says it will change the pharmaceutical industry by altering how drugs work.
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Inceptive over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
4
Stack modernity
78/100
Languages
Python
Practices & domains
Machine Learning
Edge AI
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$240k
Typical range
$240k – $305k
Open positions
5
5
Jobs
Middle
60%
Senior
40%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 3 | $240k | $240k |
| Senior | 2 | $273k | $240k – $305k |
Highest paying role
Leading data-driven lab for AI medicines
$305k
Normalized to USD per year
All salaries at Inceptive
By role, level and city, against the market · 5 jobs with pay
Growth
Hiring Momentum
68/100
Growing
Open positions
5
0 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
40% ▼
Science & Research
40% ▼
Data Science
20% ▼
Activity Timeline
New location: Zurich
Oct 2026
New location: Berlin
Oct 2026
Added Machine Learning to stack
Sep 2026
Added Agile to stack
Sep 2026
Added Notion to stack
Sep 2026
Added Linear to stack
Sep 2026
Added Edge AI to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
2
Countries
3
Busiest office
Palo Alto
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Palo Alto
United States
HQ
Palo Alto
3 open roles 33% engineering 50-200 est. staff $262k Avg Salary
hires for Sales, Data Science
3440 Hillview Ave, D100, Palo Alto, CA, 94304, US
Berlin
Germany
Regional office
Berlin
2 open roles 100% engineering 50-200 est. staff $240k Avg Salary
hires for Science & Research
Zurich
Switzerland
Regional office
Zurich
Jobs
$221k – $305k per year • In office • 6+ years exp • PhD • Palo Alto
Python
Machine Learning
Apply
Financials
Total raised
$100M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $100M | Details |